SOTIO
Sotio is an international biotechnology company leading the efforts of PPF Group to build a diverse biotechnology portfolio through its own research & development, collaborations, in-licensing, investments, mergers, and acquisitions. The company is developing new medical therapies, focusing on the treatment of cancer and autoimmune diseases. The most advanced project is the SOTIO proprietary platform of active cellular immunotherapy (ACI) based on dendritic cells.
SOTIO
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2010-01-01
Address:
Prague, Hlavni Mesto Praha, Czech Republic
Country:
Czech Republic
Website Url:
http://www.sotio.com
Total Employee:
251+
Status:
Active
Contact:
420 224 175 111
Email Addresses:
[email protected]
Total Funding:
316.87 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Nginx IPv6 JsDelivr ASP.NET
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-08-30 | CytunePharma | CytunePharma acquired by Sotio | N/A |
Investors List
PPF Group
PPF Group investment in Venture Round - Sotio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-10-14 | MaveriX Oncology | Sotio investment in Series A - MaveriX Oncology | 6.5 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-01 | SOTIO Appoints Richard Sachse as Chief Medical Officer |
Official Site Inspections
http://www.sotio.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.21 K
- Host name: host-241.ip-185-216-221.srw.cz
- IP address: 185.216.221.241
- Location: Czechia
- Latitude: 50.0848
- Longitude: 14.4112
- Timezone: Europe/Prague
More informations about "Sotio"
Sotio - Wikipedia
SOTIO Biotech [1] is a Czech biotechnology company focused on clinical-stage research and development of innovative medicines for cancer with operations in Europe, North America, and …See details»
The Company - Sotio
The Company. SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. Our robust pipeline includes a next-generation PD-1 …See details»
Sotio - Crunchbase Company Profile & Funding
Organization. Sotio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Sotio is an international biotechnology company leading the …See details»
SOTIO Company Profile | Management and Employees List
SOTIO Profile and History. SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO's robust clinical pipeline includes a …See details»
PPF Group | Sotio
SOTIO, together with PPF, and MaveriX Oncology, Inc., today announce the investment of PPF Group in MaveriX Oncology Inc., a private biotech company with a proprietary pipeline of targeted, small-molecule cancer chemo …See details»
SOTIO Biotech Pipeline
SOTIO Biotech Inc. 180 Canal St., Suite 300 Boston, MA 02114 USASee details»
Sotio - Funding, Financials, Valuation & Investors - Crunchbase
Sotio is funded by PPF Group. Sotio has invested in MaveriX Oncology on Oct 14, 2019. This investment - Series A - MaveriX Oncology - was valued at $6.5M. Sotio has acquired …See details»
SOTIO Company Profile - Office Locations, Competitors, Revenue …
SOTIO has 5 employees across 5 locations and $300 k in total funding,. See insights on SOTIO including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
SOTIO | VentureRadar
SOTIO pursues this goal through its the SOTIO® in-house research and clinical development and related services, collaborations with external partners, in-licensing deals, investments and …See details»
Company split | SCTbio
On 1st July 2021, SOTIO a.s. was split into two separate entities SOTIO a.s. and SOTIO Biotech a.s. Technical operations & Manufacturing division remain under the name SOTIO a.s. The …See details»
Sotio - Contacts, Employees, Board Members, Advisors & Alumni
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer. ... Experience the new Crunchbase, powered by AI . …See details»
SOTIO Biotech AG – Swiss Biotech
SOTIO is a biotech company building a diverse portfolio of oncology products through its own R&D, collaborations, in-licensing, investments, M&A. SOTIO is conducting multiple Phase I to …See details»
SOTIO - Overview, News & Similar companies | ZoomInfo.com
SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO's robust clinical pipeline includes a differentiated superagonist of the …See details»
SOTIO, LLC becomes a member of Massachusetts Biotechnolog...
SOTIO, LLC is a biotechnology company developing a next generation Active Cellular Immunotherapy based on activated dendritic cells for the treatment of cancer and autoimmune …See details»
SOTIO - PMC
SOTIO is running a state of the art scouting and evaluation process to identify new projects. What makes us attractive is our mid- and long-term strategy of building a fully integrated pharma …See details»
SOTIO - VentureRadar
SOTIO pursues this goal through its the SOTIO® in-house research and clinical development and related services, collaborations with external partners, in-licensing deals, investments and …See details»
Building A Broad Oncology Portfolio With SOTIO CEO Dr Radek …
Establishing an organization that can manage a diverse development pipeline for oncology therapies requires an equally diverse wealth of expertise. From in-house discovery to strategic …See details»
SOTIO Enters into Multi-Target Antibody Agreement with …
PRAGUE & BEIJING, July 16, 2024--SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, and Biocytogen (HKEX: 02315), a global biotech company focused on …See details»
Why OCIO Solutions Make Sense for Many Not-for-Profit Investors
1 day ago Why should a not-for-profit organization be interested in OCIO services? Jack: First, a lot of these organizations may not have the internal resources to manage their funds …See details»
SOTIO Bolsters Leadership Team with Appointment of Martin...
Sep 14, 2022 SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced the appointment of Martin Steegmaier, Ph.D., MBA, as chief scientific officer. …See details»